Höppener JW - Search Results

1

Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.

Gracanin A, Dreijerink KM, van der Luijt RB, Lips CJ, Höppener JW. Gracanin A, et al. Among authors: hoppener jw. Cancer Res. 2009 Aug 15;69(16):6371-4. doi: 10.1158/0008-5472.CAN-09-0678. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654304 Review.

2

Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Lips CJ, Dreijerink KM, Höppener JW. Lips CJ, et al. Among authors: hoppener jw. Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):49-56. doi: 10.6061/clinics/2012(sup01)10. Clinics (Sao Paulo). 2012. PMID: 22584706 Free PMC article. Review.

3

Menin links estrogen receptor activation to histone H3K4 trimethylation.

Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT. Dreijerink KM, et al. Among authors: hoppener jw. Cancer Res. 2006 May 1;66(9):4929-35. doi: 10.1158/0008-5472.CAN-05-4461. Cancer Res. 2006. PMID: 16651450

4

Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.

Dreijerink KM, Höppener JW, Timmers HM, Lips CJ. Dreijerink KM, et al. Among authors: hoppener jw. Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):562-70. doi: 10.1038/ncpendmet0292. Nat Clin Pract Endocrinol Metab. 2006. PMID: 17024155 Review.

5

Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.

van Veelen W, van Gasteren CJ, Acton DS, Franklin DS, Berger R, Lips CJ, Höppener JW. van Veelen W, et al. Among authors: hoppener jw. Cancer Res. 2008 Mar 1;68(5):1329-37. doi: 10.1158/0008-5472.CAN-07-5754. Cancer Res. 2008. PMID: 18316595

6

The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.

Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Höppener JW, Lips CJ, Kummer JA, Kalkhoven E, Timmers HT. Dreijerink KM, et al. Among authors: hoppener jw. Mol Cell Biol. 2009 Sep;29(18):5060-9. doi: 10.1128/MCB.01001-08. Epub 2009 Jul 13. Mol Cell Biol. 2009. PMID: 19596783 Free PMC article.

7

Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers.

Landsvater RM, de Wit MJ, Zewald RA, Hofstra RM, Buys CH, Ploos van Amstel HK, Höppener JW, Lips CJ. Landsvater RM, et al. Among authors: hoppener jw. Cancer Res. 1996 Nov 1;56(21):4853-5. Cancer Res. 1996. PMID: 8895732

8

Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.

Lips CJ, Höppener JW, Van Nesselrooij BP, Van der Luijt RB. Lips CJ, et al. Among authors: hoppener jw. J Intern Med. 2005 Jan;257(1):69-77. doi: 10.1111/j.1365-2796.2004.01429.x. J Intern Med. 2005. PMID: 15606378 Free article. Review.

9

P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development.

van Veelen W, Klompmaker R, Gloerich M, van Gasteren CJ, Kalkhoven E, Berger R, Lips CJ, Medema RH, Höppener JW, Acton DS. van Veelen W, et al. Among authors: hoppener jw. Int J Cancer. 2009 Jan 15;124(2):339-45. doi: 10.1002/ijc.23977. Int J Cancer. 2009. PMID: 18942719 Free article.

10

Multiple endocrine neoplasia type 2.

Lips CJ, van Veelen W, Links TP, Höppener JW. Lips CJ, et al. Among authors: hoppener jw. Expert Rev Endocrinol Metab. 2009 Sep;4(5):443-465. doi: 10.1586/eem.09.33. Expert Rev Endocrinol Metab. 2009. PMID: 30736185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page